Explore more publications!
Palestine Health Report
Got News to Share?

Palestine Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palestine Health Report.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 19, 2025

Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of Schwazze
Dec. 19, 2025

Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of Schwazze

Indeterminate GlobeNewswire
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
Dec. 19, 2025

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

Indeterminate GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Dec. 19, 2025

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC
Dec. 19, 2025

Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC

Indeterminate GlobeNewswire
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Dec. 19, 2025

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec. 19, 2025

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Nyxoah Announces Issuance of First Tranche of Convertible Bonds
Dec. 19, 2025

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Indeterminate GlobeNewswire
Nyxoah Annonce L’Émission de la Première Tranche des Obligations Convertibles
Dec. 19, 2025

Nyxoah Annonce L’Émission de la Première Tranche des Obligations Convertibles

Indeterminate GlobeNewswire
Lifeward Appoints Bob Marshall as Chairman of the Board
Dec. 19, 2025

Lifeward Appoints Bob Marshall as Chairman of the Board

Indeterminate GlobeNewswire
NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
Dec. 19, 2025

NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis

Indeterminate GlobeNewswire
Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)
Dec. 19, 2025

Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)

Indeterminate GlobeNewswire
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Dec. 19, 2025

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Indeterminate GlobeNewswire
Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
Dec. 19, 2025

Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms

Indeterminate GlobeNewswire
Silly Nice Welcomes Schedule III—But Says Justice Reform Must Follow
Dec. 19, 2025

Silly Nice Welcomes Schedule III—But Says Justice Reform Must Follow

Indeterminate GlobeNewswire
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Dec. 19, 2025

U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults

Indeterminate GlobeNewswire
Third-Party Recognition Underscores Genesis Healthcare’s Ongoing Commitment to Excellence in Skilled Nursing Care
Dec. 19, 2025

Third-Party Recognition Underscores Genesis Healthcare’s Ongoing Commitment to Excellence in Skilled Nursing Care

Indeterminate GlobeNewswire
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Dec. 19, 2025

Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation

Indeterminate GlobeNewswire
Communiqué de presse : Sanofi conclut un accord avec le gouvernement américain pour réduire le coût des médicaments et renforcer l’innovation
Dec. 19, 2025

Communiqué de presse : Sanofi conclut un accord avec le gouvernement américain pour réduire le coût des médicaments et renforcer l’innovation

Indeterminate GlobeNewswire
Fort Hays State University offers flexible, affordable MSN-to-DNP pathway for Advanced Practice Nurses
Dec. 19, 2025

Fort Hays State University offers flexible, affordable MSN-to-DNP pathway for Advanced Practice Nurses

Indeterminate GlobeNewswire
Salarius Pharmaceuticals Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
Dec. 19, 2025

Salarius Pharmaceuticals Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions